| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/05/2010 | US7642404 Transgenic plants with controlled distribution of a trait to progeny |
| 01/05/2010 | US7642378 Lipid lowering biphenylcarboxamides |
| 01/05/2010 | US7642345 Polynucleotides encoding human cytokine receptor |
| 01/05/2010 | US7642342 Generate immune response by activation of a T cell or a B cell to claimed peptide, nucleotide expressed in a viral vector; vaccinia, fowlpox, canarypox, adenovirus, influenza, poliovirus, adeno-associated virus, lentivirus, Sindbis virus; diagnostic and therapeutic applications |
| 01/05/2010 | US7642340 tumor necrosis factor variants covalently attached to polyethylene glycol |
| 01/05/2010 | US7642339 Hepatitis C; 1-benzyloxycarbonylamino-2-vinyl-cyclopropyl)-phenyl-phosphinic acid ethyl ester |
| 01/05/2010 | US7642338 Determining a concentration of tacrolimus or derivative thereof in a sample; using a non-specific protein capable of forming a water soluble complex with the tacrolimus |
| 01/05/2010 | US7642250 Erectile dysfunction, urinary incontinence, lung disease, hyperoxia, neurodegenerative disease, liver disease, myocardial damage during cardioplegia, an inflammatory condition, a reperfusion injury, an ischemic condition, a cardiovascular disease, diabetes, cancer |
| 01/05/2010 | US7642245 bactericide for treating drug resistant bacteria |
| 01/05/2010 | US7642244 Neuropeptide-2 receptor (Y-2R) agonists and uses thereof |
| 01/05/2010 | US7642243 Administering C-type natriuretic peptide, guanyl cyclase (GC-B)-activating peptide |
| 01/05/2010 | US7642242 Glial Cell line-derived Neurotrophic Factor Receptor; neuronal disorders, Parkinson's, Alzheimers or neuronal injury |
| 01/05/2010 | US7642241 Methods of enhancing functioning of the large intestine |
| 01/05/2010 | US7642240 Bioconjugates comprising sulfated polysaccharides and their uses |
| 01/05/2010 | US7642239 phage display; fusion proteins; kits; immunohistochemistry |
| 01/05/2010 | US7642238 Using soluble frizzled related protein 3 (SFRP-3) and/or Dickkopf-1 (DKK1) expression profiles as evaluative tools in prediciting/diagnosing bone disorders in cancer patients |
| 01/05/2010 | US7642237 Growth/differentiation factor of the TGF-β family |
| 01/05/2010 | US7642236 Recombinant lubricin molecules and uses thereof |
| 01/05/2010 | US7642235 Macrocyclic peptides active against the hepatitis C virus |
| 01/05/2010 | US7642234 Uisng Apolipoprotein H (Apo-H) as modulating agent in prevention and treatment of cell proliferative, eye, reproductive, gastrointestinal and joint disorders |
| 01/05/2010 | US7642232 Compositions and methods for the prevention and control of insulin-induced hypoglycemia |
| 01/05/2010 | US7642231 Neo-tryptophan |
| 01/05/2010 | US7642230 precipitation, freeze drying; for increasing leukocytes; pharmacokinetics |
| 01/05/2010 | US7642229 Synergistic antineoplastic effect; side effect reduction |
| 01/05/2010 | US7642228 Method for making heteromultimeric polypeptides |
| 01/05/2010 | US7642085 Polypeptide incorporating unnatural amino acid chemically bonded to solid support by a chemical linkage |
| 01/05/2010 | US7642070 Tumor suppressor gene |
| 01/05/2010 | US7642063 Methods for targeting and killing glioma cells |
| 01/05/2010 | US7642061 Using primate t-cell leukemia viruses (PTLV) envelopes to target antitumor therapeutic to cells expressing glucose transport proteins (GLUT-1) |
| 01/05/2010 | US7642054 "STRAP" and "STEAP" (six transmembrane epithelial antigen of the prostate) |
| 01/05/2010 | US7642051 Induction of mitochondrial membrane permeabilization via the physical and functional interaction of the HIV-1 Vpr protein with the mitochondrial inner membrane protein ANT (also called adenine nucleotide translocase or ADP/ATP carrier) |
| 01/05/2010 | US7642044 Trimerising module |
| 01/05/2010 | US7641924 Proteins, lipids and carbohydrates including glucose and fructose heterodisaccharides; slow hydrolysis |
| 01/05/2010 | US7641905 Methods of inducing an immune response |
| 01/05/2010 | US7641901 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 01/05/2010 | US7641900 Combining collagen with a substance which enhances the collagen's normal debridement effect, and to do so through the use of readily available ingredients and in a manner which enables the components when stored to have an adequate shelf life |
| 01/05/2010 | US7641899 Methods for inhibiting IL-TIF-induced proliferation of hematopoietic cells using the cytokine receptor Zcytor16 |
| 01/05/2010 | US7641898 cells are dispersed using an air-jet sprayer after being suspended in a soluble media either directly onto the area or onto a tissue scaffold to form three dimensional epithelial tissue |
| 01/05/2010 | US7641895 Peptides for active anti-cytokine immunization |
| 01/05/2010 | US7641894 Stimulating neutrophil function to treat inflammatory bowel disease |
| 01/05/2010 | US7641823 Synthesis of small particles |
| 01/05/2010 | US7641643 Methods and compositions to treat myocardial conditions |
| 01/05/2010 | CA2473503C Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
| 01/05/2010 | CA2456183C Il-6/ds-sil-6r fusion protein |
| 01/05/2010 | CA2429162C Methods and compositions for enhancing cellular function through protection of tissue components |
| 01/05/2010 | CA2332642C Method for producing or enhancing a t-cell response against a target cell using a complex comprising an hla class i molecule and an attaching means |
| 01/05/2010 | CA2318192C .beta.2-adrenergic receptor agonists |
| 01/05/2010 | CA2300480C Methods and compositions for therapies using genes encoding secreted proteins such as interferon-beta |
| 01/05/2010 | CA2287780C Use of nerve growth factor for the storage, culture or treatment of cornea |
| 01/05/2010 | CA2281877C Psca: prostate stem cell antigen |
| 01/05/2010 | CA2202496C Neurotrophic peptides of activity dependent neurotrophic factor |
| 01/05/2010 | CA2182810C Bacteriocin from micrococcus varians |
| 01/05/2010 | CA2062763C Cytokine synthesis inhibitory factor, antagonists thereof, and methods of using same |
| 12/31/2009 | US20090327170 Methods of Clustering Gene and Protein Sequences |
| 12/31/2009 | US20090326607 Electrical Stimulation Method for Treatment of Peripheral Neuropathy |
| 12/31/2009 | US20090326206 Single-chain Multiple Antigen-binding Molecule, Its Preparation and Use |
| 12/31/2009 | US20090326039 Inhibitors for the soluble epoxide hydrolase |
| 12/31/2009 | US20090326038 Method for treating a immunology-related disease |
| 12/31/2009 | US20090325895 Methods of treating an inflammatory-related disease |
| 12/31/2009 | US20090325889 Hepatitis c serine protease inhibitors and uses therefor |
| 12/31/2009 | US20090325888 Peptides having a health benefit and compositions comprising them |
| 12/31/2009 | US20090325887 Peptides and regulation of calcium channels |
| 12/31/2009 | US20090325886 Wt1 modified peptide |
| 12/31/2009 | US20090325885 Composition for acceleration of type i collagen production |
| 12/31/2009 | US20090325884 Method for Detecting Autoantibodies Formed in Rheumatoid Arthritis |
| 12/31/2009 | US20090325883 Peptides Which Interact with Anti-Apoptotic Members of the BCL-2 Protein Family, and Uses |
| 12/31/2009 | US20090325882 Chaperonin 10 modulation of toll-like receptor-inducible cytokine and chemokine secretion |
| 12/31/2009 | US20090325881 Modified factor viii |
| 12/31/2009 | US20090325880 Tnf receptor-like molecules and uses thereof |
| 12/31/2009 | US20090325879 Controlled release copolymer formulation with improved release kinetics |
| 12/31/2009 | US20090325878 Organ preconditioning, arrest, protection, preservation and recovery |
| 12/31/2009 | US20090325877 Combination Product of Receptor Tyrosine Kinase Inhibitor and Fatty Acid Synthase Inhibitor for Treating Cancer |
| 12/31/2009 | US20090325876 Use of lipid conjugates in the treatment of diseases associated with vasculature |
| 12/31/2009 | US20090325875 Muteins of human tear lipocalin |
| 12/31/2009 | US20090325874 Inhibition of inositol 1,4,5-triphosphate receptor calcium channel/cytochrome c interactions and uses thereof |
| 12/31/2009 | US20090325873 Human glp-1 mimetibodies, compositions, methods and uses |
| 12/31/2009 | US20090325872 Use of alpha-lactalbumin for regulations of glycemia |
| 12/31/2009 | US20090325871 Role of the Mk2 Pathway in Wound Repair |
| 12/31/2009 | US20090325870 Foamy viral envelope genes |
| 12/31/2009 | US20090325869 Synthetic regulators of ferritin protein nanocage pores and methods of use thereof |
| 12/31/2009 | US20090325868 Materials And Methods For FOXP3 Tumor Suppression |
| 12/31/2009 | US20090325867 Receptor-specific tumour necrosis factor-related apoptosis-inducing ligand (trail) variants |
| 12/31/2009 | US20090325866 Non-activated wnt inhibition polypeptides and method for preparing the same |
| 12/31/2009 | US20090325865 Liquid Formulations of Pegylated Growth Hormone |
| 12/31/2009 | US20090325864 Novel protein and process for preparing the same |
| 12/31/2009 | US20090325863 Somatostatin analogs and IGF-I inhibition for breast cancer prevention |
| 12/31/2009 | US20090325862 Histone Deacetylase Inhibitors for the Treatment of Neurodegeneration |
| 12/31/2009 | US20090325861 Dry wound dressing and drug delivery system |
| 12/31/2009 | US20090325860 Compositions for intranasal delivery of human insulin and uses thereof |
| 12/31/2009 | US20090325859 Citric acid polymers |
| 12/31/2009 | US20090325858 Reduction of Zinc-Induced Neurotoxic Injury By Blockade of Nitric Oxide Synthesis |
| 12/31/2009 | US20090325857 Use of opioid receptor antagonists |
| 12/31/2009 | US20090325856 Composition Designed For The Treatment Of Multiple Sclerosis |
| 12/31/2009 | US20090325228 Fungal cell wall synthesis gene |
| 12/31/2009 | US20090324777 Method of producing a palatability enhancer that can add health value to foodstuffs |
| 12/31/2009 | US20090324741 Injectable polymer-lipid blend |
| 12/31/2009 | US20090324733 Composition of Whey Growth Factor Extract for Reducing Muscle Inflammation |
| 12/31/2009 | US20090324730 Methods and compositions for the treatment of symptoms of complex regional pain syndrome |
| 12/31/2009 | US20090324725 Peg-modified hydroxyapatite, pharmaceutical using the same as base material and production process thereof |
| 12/31/2009 | US20090324720 Biocompatible crosslinked hydrogels, drug-loaded hydrogels and methods of using the same |